// App-Quantinova.ai

: External Validation of the FLIPI Risk Score Measured at Initial Diagnosis and POD24 Among Previously Treated Individuals with Progressed Follicular Lymphoma in Alberta, Canada

Researchers

Presenter

  • Carolyn Owen

Principal Investigators

  • Neil Chua

  • Devon Boyne

  • Ofodile Joe-Uzuegbu

  • Huma Shakir

  • Priyanka Gonga

  • Darren Brenner

  • Julia Elia-Pacitti

  • Emmanuel Ewara

  • Winson Y Cheung

Medical Centers

  • Oncology Outcomes Research Initiative, University of Calgary, Calgary, Canada

  • Cross Cancer Institute, University of Alberta, Edmonton, Canada

  • Department of Community Health Science, University of Calgary, Calgary, Canada

  • Departments of Medicine and Oncology, University of Calgary, Calgary, Canada

  • Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Follicular lymphoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A